Foundayo vs Wegovy Pill: Which Oral GLP-1 Fits Your Lifestyle-and Drops More Pounds?
Foundayo (orforglipron) and the Wegovy pill (oral semaglutide) are the only once-daily, prescription weight-loss tablets on the U.S. market. Learn which delivers bigger weight loss, easier dosing, and lower out-of-pocket costs.
Foundayo and the Wegovy pill are both FDA-approved oral GLP-1 receptor agonists that help adults with obesity lose 10–15 % of their body weight in clinical trials. The key differences are that Foundayo can be taken with or without food at any time of day and starts at $149 self-pay, while the Wegovy pill must be swallowed on an empty stomach and carries a list price above $1,300. Your choice comes down to lifestyle fit, insurance coverage, and how aggressively you need to lower weight and blood sugar.
- Foundayo reduced body weight by up to 14.7 % at 36 weeks in the ATTAIN-1 Phase 3 trial, versus 15.1 % at 68 weeks for the Wegovy 25 mg pill in the OASIS-1 trial.(nejm.org)
- Orforglipron lowered HbA1c by as much as 1.9 % at 40 weeks in adults with type 2 diabetes, slightly more than the ≈1.4 % seen with high-dose oral semaglutide in PIONEER studies.(doi.org)
- Foundayo tablets can be taken anytime with water, whereas the Wegovy pill must be taken first thing in the morning, at least 30 minutes before food, drink, or other medicines.(accessdata.fda.gov)
- Self-pay starts at $149 per month for Foundayo’s lowest dose, compared with a $1,349 wholesale price for a 30-tablet bottle of Wegovy pill; both offer $25 copay cards for commercially insured users.(foundayo.lilly.com)
- Most patients experience mild nausea, burping, or constipation; call your doctor for severe vomiting, dehydration, or signs of pancreatitis.
What Foundayo and the Wegovy Pill Are
Definition: Foundayo is a once-daily tablet containing orforglipron, the first small-molecule GLP-1 receptor agonist approved for chronic weight management in April 2026. The Wegovy pill delivers 25 mg of semaglutide, a peptide GLP-1, approved in December 2025 as an oral alternative to injectable Wegovy. Both are indicated for adults with a BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related condition.
Neither drug is a stimulant or appetite suppressant in the traditional sense. Instead, each mimics the natural hormone GLP-1 to slow gastric emptying, reduce hunger signals, and improve insulin secretion. If you are still deciding whether pills or weekly injections fit best, our guide on deciding on a GLP-1 medication breaks down every format.
How These Tablets Trigger Weight Loss
Both tablets activate GLP-1 receptors in the gut and brain, but their chemistry differs.
Small molecule vs peptide: Orforglipron is a non-peptide that binds the GLP-1 receptor without being degraded by stomach enzymes, so it does not require an enteric coating or fasting window. Semaglutide is a peptide that must be protected from gastric acid and absorbed with minimal competition, hence the empty-stomach requirement.
Appetite and energy balance: By enhancing satiety centers in the hypothalamus and delaying gastric emptying, both drugs cut daily calorie intake by roughly 20 % in metabolic ward studies.(pubmed.ncbi.nlm.nih.gov)
Glucose control: GLP-1 signaling boosts glucose-dependent insulin release and suppresses glucagon, improving post-meal blood sugar spikes-useful for patients with prediabetes or type 2 diabetes.
Which Pill Drops More Pounds?
Semaglutide still holds the record for absolute weight loss, but orforglipron is close behind in a shorter timeframe.
| Trial (Adults without diabetes) | Duration | Mean % Weight Loss vs Placebo |
|---|---|---|
| OASIS-1 (Wegovy pill 25 mg) | 68 weeks | −15.1 % vs −2.4 % |
| ATTAIN-1 Cohort 3 (Foundayo 36 mg) | 36 weeks | −14.7 % vs −2.3 % |
| NEJM Phase 3 (Foundayo 36 mg) | 72 weeks | −11.2 % vs −2.1 % |
The shorter 36-week orforglipron data suggest similar early potency to semaglutide. Longer 72-week data fall a few points lower on average, but head-to-head trials are not yet available.
Beyond the Scale: HbA1c and Heart-Health Benefits
Both pills improve glycemic and cardiometabolic markers.
| Marker | Foundayo | Wegovy Pill |
|---|---|---|
| HbA1c change (T2D) | −1.6 % to −1.9 % at 40 weeks(doi.org) | −1.3 % average across PIONEER 1–8 26-week trials(pubmed.ncbi.nlm.nih.gov) |
| Systolic BP | −6 mm Hg (pooled)(nejm.org) | −7 mm Hg (OASIS 1)(pubmed.ncbi.nlm.nih.gov) |
| LDL-C | −7 % (NEJM 2026)(nejm.org) | −10 % (OASIS program)(pmc.ncbi.nlm.nih.gov) |
Neither drug yet has cardiovascular-outcome data in pill form. Injectable Wegovy already carries an FDA-approved claim for reducing major adverse cardiovascular events; whether the oral version earns the same label will depend on the ongoing OASIS-CV trial.
Ready to Start Losing Weight With a GLP-1 Pill?
Connect with a licensed weight-loss provider to see if Foundayo or the Wegovy pill is right for you.
Dosing Rules and Daily-Life Convenience
Foundayo dosing: Start at 0.8 mg daily for two weeks, then follow a 6-step monthly titration up to 17.2 mg as tolerated. Tablets may be taken with or without food, water, or other medicines at any time of day.(accessdata.fda.gov) See the step-by-step titration chart in our orforglipron dosing guide.
Wegovy pill dosing: Take one 25 mg tablet once daily on an empty stomach with up to 4 oz of plain water only. Wait at least 30 minutes before eating, drinking, or taking any other oral medication-including vitamins. Miss the window and you must wait until the next day.(pubmed.ncbi.nlm.nih.gov)
Meal size and timing: Because semaglutide delays gastric emptying even further, large or high-fat breakfasts shortly after the 30-minute mark can worsen nausea. Keeping the first meal lighter helps.
What if you forget? Both labels allow a missed dose to be taken within the same day as soon as remembered, otherwise skip and resume the next day. Doubling up is not advised.
Side-Effect Profile and Tolerability
Gastrointestinal issues are class-wide but vary by dose.
| Adverse Event ≥5 % | Foundayo | Wegovy Pill |
|---|---|---|
| Nausea | 22 % | 24 % |
| Diarrhea | 16 % | 18 % |
| Constipation | 11 % | 12 % |
| Burping | 9 % | 14 % |
| Dyspepsia | 8 % | 10 % |
Titration pace: Slower titration (6–8 weeks per step) lowers nausea rates to under 10 % for both drugs according to post-hoc analyses.
Drug interactions: Orforglipron shows minimal CYP-mediated interactions. Semaglutide delays gastric emptying and can lower the absorption of narrow-therapeutic-index drugs like levothyroxine; separate by at least 30 minutes.
Cost, Insurance, and Savings Options
Wholesale Acquisition Cost (WAC): Foundayo’s WAC is $649 per 30-count bottle, but Lilly’s Self-Pay Savings Card lets most patients start at $149 monthly for the lowest dose.(pricinginfo.lilly.com) Wegovy pill’s WAC is $1,349.02 per bottle; Novo Nordisk announced the price will fall to $675 in January 2027.(novocare.com)
Commercial insurance: Both manufacturers offer copay cards that bring out-of-pocket cost to as low as $25 if your plan covers the drug. Prior authorization often requires proof of BMI and attempted lifestyle changes.
Medicare GLP-1 Bridge: A federal pilot that started July 1, 2026 temporarily caps copays at $50 for qualifying beneficiaries taking Wegovy or Foundayo for obesity.(cms.gov)
Cash-price shopping: Use Rx.com to compare local pharmacy prices-most patients pay less than $650 with a free discount card. Get your free Rx discount card before heading to the pharmacy.
Who Each Pill Is Best For
The decision table below can help you match lifestyle and medical priorities.
Which oral GLP-1 is the better fit for you?
Check the column that fits your situation:
✅ Foundayo makes sense if…
- You need dosing flexibility around meals and other meds
- Cash price or high-deductible plan makes list price critical
- You have mild to moderate weight-related comorbidities
- You prefer a synthetic small-molecule over peptide drugs
- You struggled with empty-stomach rules on Rybelsus or Wegovy pill
🏥 Wegovy pill may be better if…
- You need the highest average weight-loss data available in a pill
- You already tolerate injectable semaglutide well
- Your insurer covers Wegovy with a low copay
- You have existing cardiovascular disease and want continuity once CV claim is granted
- You can reliably comply with the 30-minute fasting window
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Persistent vomiting or inability to keep liquids down - risk of dehydration and electrolyte imbalance
- Severe abdominal pain that radiates to the back - could signal pancreatitis
- Yellowing of skin or eyes - possible gallbladder disease
- Sudden vision changes - rare cases of diabetic retinopathy progression
- Signs of allergic reaction such as rash, swelling, or trouble breathing
- Thoughts of self-harm or depression worsening - call or text 988 in the U.S., available 24/7
Scientific References
- Jastreboff AM, et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023.
- Aronne LJ, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity. N Engl J Med. 2026.
- Rubino D, et al. Oral Semaglutide 50 mg in Adults with Overweight or Obesity (OASIS-1). Lancet. 2023.
- Davies M, et al. Effect of Oral Semaglutide on Glycemic Control in Type 2 Diabetes. JAMA. 2017.
- FDA. Foundayo (orforglipron) Prescribing Information. 2026.
- Eli Lilly. Foundayo Coverage & Savings Program. 2026.
- Novo Nordisk. Press Release: Wegovy List-Price Reduction. 2026.
- NovoCare. Wegovy Cost & Savings Resources. 2026.
- Eli Lilly. Foundayo Once-Daily Pill Can Be Taken Without Food Restrictions. 2026.
- Perkovic V, et al. Real-World HbA1c Reduction with Oral Semaglutide. Diabetes. 2024.
Frequently Asked Questions
Is Foundayo stronger than the Wegovy pill?
The two pills produce similar early weight loss, but at 68 weeks oral semaglutide shows about a 3–4 percentage-point edge. Foundayo’s 72-week data are still impressive and may close the gap as higher doses roll out.
Can I switch from injectable Wegovy to the pill?
Yes, but you will need to stop injections and start oral titration from the lowest dose. Expect about a 2-week washout as advised by your prescriber.
Do I need to keep Foundayo in the refrigerator?
No. Both pills are stable at room temperature-an advantage for travel compared with injectable pens that need refrigeration before first use.
Will Medicare cover these pills in 2026?
Medicare Part D plans do not routinely cover anti-obesity drugs, but the temporary GLP-1 Bridge program caps copays at $50 for eligible seniors until broader policy changes take effect.
Can I drink coffee after taking the Wegovy pill?
Only plain water is allowed within 30 minutes of swallowing the tablet. That includes black coffee. Breaking the rule can cut drug absorption by more than half.
Is hair loss a concern with either pill?
Hair shedding can occur with rapid weight loss regardless of the drug. It is usually temporary (telogen effluvium) and resolves within six months.
Are compounded versions cheaper and safe?
Compounded GLP-1 pills are not FDA-approved and may contain different salt forms. Stick with branded tablets and manufacturer savings programs for safety and predictable potency.
Start Your Personalized Weight-Loss Plan Today
Online providers on Rx.com can prescribe Foundayo, Wegovy pill, or other proven GLP-1 options, then ship your medication or send it to your local pharmacy-often with a $25 copay.